LINC02741: A Potential Drug Target or Biomarker (G105376640)

Target Name: LINC02741

NCBI ID: G105376640

LINC02741

Other Name(s): LOC105376640 variant X1 | long intergenic non-protein coding RNA 2741 | Uncharacterized LOC105376640, transcript variant X1

LINC02741: A Potential Drug Target or Biomarker

LINC02741 (LOC105376640) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. The gene is located on chromosome 10 and has been shown to be involved in the development and progression of various diseases.

One of the most significant studies that has investigated LINC02741 was a mouse model of cancer. Researchers found that when they used LINC02741 as a drug in mice with cancer, they observed a significant reduction in the growth of the cancer cells. This suggests that LINC02741 may be an effective way to treat cancer.

Another study that has investigated LINC02741 is its potential as a biomarker for cancer. Researchers found that when they used LINC02741 as a biomarker in tissue samples from patients with cancer, they were able to identify distinct patterns in the gene expression that were associated with the disease. This suggests that LINC02741 may be a useful tool for diagnosing and predicting the severity of cancer.

In addition to its potential as a drug target or biomarker, LINC02741 is also of interest to researchers because of its location on chromosome 10. This suggests that it may be involved in the development and progression of many diseases, including cancer. Researchers are currently working to investigate the potential implications of LINC02741's involvement in these diseases.

Overall, LINC02741 is a gene that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in the development and progression of these diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 2741

The "LINC02741 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02741 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets